Question 1

What does Inotiv do?

Accepted Answer

Inotiv provides biopharmaceutical analytical, reproductive toxicology, medical device testing, DMPK, consulting and pathological services.

Question 2

In what sectors does Inotiv operate?

Accepted Answer

Inotiv operates in Biopharma, Life Science, Medical Device, Pharmaceutical.

Question 3

How many companies has Inotiv acquired?

Accepted Answer

Inotiv has made 5 acquisitions between 2021-2022, with a total disclosed deal value of $297.0M.

Question 4

How many acquisitions does Inotiv make in a year?

Accepted Answer

Over the last 5 years, Inotiv has made about 1 acquisitions per year.

Question 5

What companies are owned by Inotiv?

Accepted Answer

Companies acquired by Inotiv include Protypia, Histion, LLC, Envigo, Plato BioPharma, Gateway Pharmacology Laboratories.

Question 6

What are Inotiv's major acquisitions?

Accepted Answer

Inotiv's largest acquisitions include Envigo ($271.0M, 2021), Plato BioPharma ($15.0M, 2021), Protypia ($11.0M, 2022).

Question 7

What is Inotiv's largest acquisition?

Accepted Answer

Inotiv's largest disclosed acquisition is Envigo for $271.0M (2021).

Question 8

What was Inotiv's first acquisition?

Accepted Answer

Inotiv's first recorded acquisition was Gateway Pharmacology Laboratories in 2021.

Question 9

What was Inotiv's most recent acquisition?

Accepted Answer

Inotiv's most recent acquisition is Protypia, announced July 2022 for $11.0M.

Question 10

What is the average deal size for Inotiv acquisitions?

Accepted Answer

The average disclosed deal size for Inotiv acquisitions is $99.0M.

Question 11

What is the median deal size for Inotiv acquisitions?

Accepted Answer

The median disclosed deal size for Inotiv acquisitions is $15.0M. The median is often lower than the average because a few very large deals pull the average up.

Question 12

How much has Inotiv spent on acquisitions?

Accepted Answer

Inotiv has spent at least $297.0M across its disclosed acquisitions (of 5 total deals; some prices are undisclosed).

Question 13

Which sector has Inotiv spent the most on?

Accepted Answer

Inotiv has committed the most disclosed capital to Biotechnology companies — about $297.0M across its deals in that sector.

Question 14

What sectors does Inotiv usually acquire in?

Accepted Answer

Inotiv most frequently acquires companies in Biotechnology, Pharmaceutical, Biopharma.

Question 15

In which sector has Inotiv made the most acquisitions?

Accepted Answer

Inotiv has made the most acquisitions in the Biotechnology sector.

Question 16

In which year did Inotiv make the most acquisitions?

Accepted Answer

Inotiv made the most acquisitions in 2021, with 3 deals.

Datasets

Top Companies

Top Industries

Years (1990-2026)

Inotiv

Company Details

Funding & Financials

Web Traffic

Company Info

Acquisitions by Inotiv

Key People at Inotiv

Explore 200,000+ acquisitions — free

Recent News related to Inotiv

FAQs about Inotiv

People who checked this page also checked these